Allergies

Allergies

09-07-2014 - 10-07-2014 London, United KingdomHoliday Inn, Regents Park

The Allergies conference will examine novel approaches in the treatment of allergy, advances in the understanding of allergic pathophysiology: therapeutic implications, food allergies - what is new? The future of allergen-specific immunotherapy and challenges in allergy prevention, diagnosis and drug development will be explored.

The Allergies conference will examine novel approaches in the treatment of allergy, advances in the understanding of allergic pathophysiology: therapeutic implications, food allergies - what is new? The future of allergen-specific immunotherapy and challenges in allergy prevention, diagnosis and drug development will be explored. 

Why Attend?

  • Evaluate new breakthroughs in allergy treatment
  • Gain understanding into guidance on development novel therapeutics
  • Developing immunotherapies that are better today
  • Exclusive case study on the success of peanut allergy trials

Who should attend?

This event is aimed at Chief Executives, Chief Scientific Officers, Presidents, Senior Vice Presidents, Vice Presidents, Heads, Senior Directors, Directors, Clinicians, Principal Scientists, Research Fellows, Principal Investigators, Managers, Project/Team Leaders in: 

  • Immunotherapy Drug Discovery
  • Allergy Medicine
  • Allergy Pharmacology
  • Immunotherapy
  • Research Immunology
  • Pharmacology 
  • Immunotherapy Licensing 
  • Inflammation and Autoimmunity 
  • Immunology 
  • Allergy Cell Biology 
  • Allergy Therapeutics 
  • Allergy Devices
  • Medical Devices 
  • Inflammation Discovery 
  • Allergy Medicine Regulation

 

Company Spotlight

ImmunoGen

ImmunoGen

Ario Pharma

ario-pharma-small.jpg

Ario Pharma is a UK-based biopharmaceutical company that focuses on the development of drugs for the treatment of respiratory indications.

Back to top